Suppr超能文献

甲状腺肿瘤的N-ras突变,特别涉及滤泡型。

N-ras mutation of thyroid tumor with special reference to the follicular type.

作者信息

Oyama T, Suzuki T, Hara F, Iino Y, Ishida T, Sakamoto A, Nakajima T

机构信息

Second Department of Pathology, Gunma University School of Medicine, Maebashi, Japan.

出版信息

Pathol Int. 1995 Jan;45(1):45-50. doi: 10.1111/j.1440-1827.1995.tb03378.x.

Abstract

Using the method of polymerase chain reaction-single strand conformation polymorphism, the point mutations of the ras oncogenes in a total of 33 thyroid tissues, including 12 follicular adenomas, 6 follicular carcinomas, 11 papillary carcinomas, and 4 undifferentiated carcinomas, were examined. The frequency of the mutation was 3% (1/33) in codon 12, 13 of Ki-ras and 18% (6/33) in codon 61 of N-ras, including 17% (2/12) in follicular adenoma, 50% (3/6) in follicular carcinoma, 0% (0/11) in papillary carcinoma and 25% (1/4) in undifferentiated carcinoma. In follicular adenoma, positivity was observed in microfollicular or trabecular subtypes. Furthermore, the mutation of ras, was examined in histologically different parts, coexisting in the same tumor in a total of four cases. Both the undifferentiated carcinoma and coexisting follicular adenoma, and both the microfollicular adenoma and trabecular nodule growing in the tumor, had the same N-ras (61) mutation. Direct sequencing analysis showed that all mutations were CAA (Gln) to CGA (Arg) transition of codon 61, except for CAA to AAA transversion in one case of follicular carcinoma. A similar genetic abnormality of N-ras genes at codon 61 between follicular adenoma and follicular carcinoma suggests that the mutation of N-ras at codon 61 might play a part in oncogenesis in follicular tumors.

摘要

采用聚合酶链反应-单链构象多态性方法,检测了总共33例甲状腺组织中ras癌基因的点突变,其中包括12例滤泡性腺瘤、6例滤泡性癌、11例乳头状癌和4例未分化癌。Ki-ras基因第12、13密码子的突变频率为3%(1/33),N-ras基因第61密码子的突变频率为18%(6/33),其中滤泡性腺瘤中为17%(2/12),滤泡性癌中为50%(3/6),乳头状癌中为0%(0/11),未分化癌中为25%(1/4)。在滤泡性腺瘤中,微滤泡型或小梁型亚型呈阳性。此外,在总共4例同一肿瘤中组织学不同部分共存的病例中检测了ras的突变。未分化癌与共存的滤泡性腺瘤,以及肿瘤中生长的微滤泡性腺瘤和小梁状结节,均具有相同的N-ras(61)突变。直接测序分析表明,除1例滤泡性癌为CAA到AAA的颠换外,所有突变均为第61密码子的CAA(谷氨酰胺)到CGA(精氨酸)的转换。滤泡性腺瘤和滤泡性癌之间第61密码子N-ras基因的类似基因异常表明,第61密码子N-ras的突变可能在滤泡性肿瘤的肿瘤发生中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验